Form 8-K - Current report:
SEC Accession No. 0001206774-14-003291
Filing Date
2014-11-18
Accepted
2014-11-18 07:30:47
Documents
16
Period of Report
2014-11-18
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT geron_8k.htm 8-K 12250
2 STIFEL 2014 HEALTHCARE CONFERENCE PRESENTATION exhibit99-1.htm EX-99.1 2392
3 GRAPHIC exhibit99x10x1.jpg GRAPHIC 169683
4 GRAPHIC exhibit99x11x1.jpg GRAPHIC 204319
5 GRAPHIC exhibit99x12x1.jpg GRAPHIC 158013
6 GRAPHIC exhibit99x13x1.jpg GRAPHIC 240108
7 GRAPHIC exhibit99x14x1.jpg GRAPHIC 79184
8 GRAPHIC exhibit99x1x1.jpg GRAPHIC 69685
9 GRAPHIC exhibit99x2x1.jpg GRAPHIC 268802
10 GRAPHIC exhibit99x3x1.jpg GRAPHIC 238389
11 GRAPHIC exhibit99x4x1.jpg GRAPHIC 234497
12 GRAPHIC exhibit99x5x1.jpg GRAPHIC 203742
13 GRAPHIC exhibit99x6x1.jpg GRAPHIC 168946
14 GRAPHIC exhibit99x7x1.jpg GRAPHIC 239509
15 GRAPHIC exhibit99x8x1.jpg GRAPHIC 198384
16 GRAPHIC exhibit99x9x1.jpg GRAPHIC 196730
  Complete submission text file 0001206774-14-003291.txt   3696607
Mailing Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20859 | Film No.: 141229569
SIC: 2834 Pharmaceutical Preparations